Convocatoria de Expresiones de Interés del Clúster de Salud de Horizonte Europa

Programa de Trabajo extraordinario COVID-19 en el contexto de la comunicación de la Comisión: HERA Incubator: Anticipando juntos la amenaza de las variantes de COVID-19.

Convocatoria de Expresiones de Interés del Clúster de Salud

  • Condiciones especiales:
    • Elegibilidad países: In particular, due to the urgency of this action and geographical relevance of this action and considering the Union’s interest to retain, in principle, relations with the countries associated to Horizon 2020, and other third countries in the process of association to Horizon Europe, legal entities established in Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo*, Moldova, Montenegro, Morocco, North Macedonia, Norway, Serbia, Switzerland, Tunisia, Turkey, Ukraine and United Kingdom are eligible for funding from the Union even if the Horizon Europe association agreement with the third country concerned does not apply at the time of signature of the grant agreement.
    • Evaluación: In order to ensure a balanced portfolio covering responses to different aspects of the public health emergency under the specific actions above, and within each specific action, grants will be awarded to applications not only in order of ranking, but also to those projects that enhance the quality of the project portfolio through synergies between projects and avoidance of overlaps, provided that the applications attain all thresholds.
    • Disposiciones de emergencia pública: beneficiaries must comply with the public emergency related provisions listed in the General Annexes of the Work Programme 2021 (part G – Legal and financial set-up of the grant agreements) and in the Model Grant Agreement concerning the project implementation under Intellectual Property Rights (IPR), background and results, access rights and rights of use (article 16 and Annex 5) for the duration of the pandemic; and under Communication, dissemination, open science and visibility (article 17 and Annex 5) during the entire duration of the action and for four years after the end of the action.
    • Formulario para estudios en humanos.

Otra información publicada de interés NO correspondiente al Clúster de Salud:

Fuente: UPV







RUVID - Red de Universidades
Valencianas para el fomento de la
Investigación, el Desarrollo y la Innovación

C/Serpis, 29 · 2ª planta
Edificio INTRAS
46022 · Valencia · España
Tel: +34 96 162 54 61
ruvid@ruvid.org

©RUVID, Red de Universidades Valencianas para el fomento de la Investigacción, el Desarrollo y la Innovación
​Protección de datos ​Política de cookies